Your browser doesn't support javascript.
loading
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus.
Smith, Michael A; Chiang, Chia-Chien; Zerrouki, Kamelia; Rahman, Saifur; White, Wendy I; Streicher, Katie; Rees, William A; Schiffenbauer, Adam; Rider, Lisa G; Miller, Frederick W; Manna, Zerai; Hasni, Sarfaraz; Kaplan, Mariana J; Siegel, Richard; Sinibaldi, Dominic; Sanjuan, Miguel A; Casey, Kerry A.
Afiliação
  • Smith MA; AstraZeneca, Gaithersburg, MD, USA.
  • Chiang CC; AstraZeneca, Gaithersburg, MD, USA.
  • Zerrouki K; AstraZeneca, Gaithersburg, MD, USA.
  • Rahman S; AstraZeneca, Gaithersburg, MD, USA.
  • White WI; AstraZeneca, Gaithersburg, MD, USA.
  • Streicher K; AstraZeneca, Gaithersburg, MD, USA.
  • Rees WA; AstraZeneca, Gaithersburg, MD, USA.
  • Schiffenbauer A; Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Rider LG; Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Miller FW; Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Manna Z; Lupus Clinical Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Hasni S; Lupus Clinical Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Kaplan MJ; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD, USA.
  • Siegel R; Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Sinibaldi D; AstraZeneca, Gaithersburg, MD, USA. dominic.sinibaldi@astrazeneca.com.
  • Sanjuan MA; AstraZeneca, Gaithersburg, MD, USA.
  • Casey KA; AstraZeneca, Gaithersburg, MD, USA. kerry.casey@bms.com.
Sci Rep ; 10(1): 4462, 2020 03 10.
Article em En | MEDLINE | ID: mdl-32157125
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Biomarcadores / Interferon Tipo I / Proteoma / Anticorpos Monoclonais Humanizados / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Biomarcadores / Interferon Tipo I / Proteoma / Anticorpos Monoclonais Humanizados / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article